IllumiCell AI Successfully Completes Regulation Crowdfunding Capital Raise
ICON Capital Group Serves as a Broker-of-Record for Financially Supporting the Future of AI-Powered Cellular Analysis
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
NEWPORT BEACH, Calif., July 16, 2026 (KOREWIRE)— ICON Capital Group, LLC (“ICON”), a boutique investment banking and capital markets advisory firm, today announced the successful completion of a Regulation Crowdfunding (Reg CF) capital raise for IllumiCell AI https://www.illumicell.ai/ , an innovative healthcare technology company leveraging artificial intelligence to transform cellular imaging and diagnostics. ICON Capital Group served as the broker-of-record for the offering, which was led by MedTech Syndicates and supported by a growing community of investors committed to advancing next-generation medical technologies.
The successful financing provides IllumiCell AI with growth capital to accelerate product development, expand commercialization efforts, and advance its mission of delivering AI-powered solutions that improve the speed, accuracy, and accessibility of cellular analysis across healthcare and life science applications.
“Completing this Reg CF offering represents an important milestone for IllumiCell AI and demonstrates strong investor confidence in the company’s vision and technology,” said John Calicchio, Chief Executive Officer of ICON Capital Group. “We are proud to have served as broker-of-record and to have partnered with MedTech Syndicates in bringing this opportunity to a broad network of investors who recognize the transformative potential of artificial intelligence in healthcare.”
IllumiCell AI is developing advanced artificial intelligence technologies designed to enhance cellular imaging, diagnostics, and research workflows. By combining machine learning with sophisticated image analysis, the company aims to help healthcare professionals and researchers generate faster, more accurate insights while improving operational efficiency and patient outcomes.
“The support we received from investors throughout this offering validates both our mission and the market opportunity ahead of us,” said CEO Michel Bielecki, MD. “We appreciate the leadership of MedTech Syndicates and the expertise of ICON Capital Group in helping us successfully complete this financing. The proceeds will enable us to accelerate key strategic initiatives and continue building innovative AI-driven solutions for the healthcare industry.”
MedTech Syndicates, known for identifying and supporting disruptive medical technology companies, led the investor syndicate participating in the offering.
“IllumiCell AI represents the convergence of two powerful trends—artificial intelligence and precision healthcare,” said CEO Gavin Leonard. “We believe the company’s technology platform addresses significant opportunities within diagnostic and research markets, and we are excited to support its continued growth.”
The transaction highlights the increasing role of Regulation Crowdfunding as a capital formation tool for emerging healthcare and technology companies seeking to engage both accredited and non-accredited investors while building strong stakeholder communities around their businesses.
About IllumiCell AI
IllumiCell AI is a healthcare technology company focused on applying artificial intelligence and advanced image analysis to cellular imaging and diagnostics. The company’s solutions are designed to enhance clinical decision-making, accelerate research, and improve healthcare outcomes through intelligent data-driven insights. For more information, visit www.illumicell.ai.
About MedTech Syndicates
MedTech Syndicates is a leading investor network dedicated to identifying, funding, and supporting breakthrough medical technology and healthcare innovation companies. The organization provides capital, strategic guidance, and industry expertise to entrepreneurs developing transformative healthcare solutions. https://www.medtechsyndicates.
About ICON Capital Group, LLC
ICON Capital Group, LLC is a boutique investment banking and advisory firm specializing in capital formation, mergers and acquisitions, strategic advisory, and corporate finance solutions for emerging growth and middle-market companies. Through its extensive investor network and industry expertise, ICON helps innovative companies access the capital and strategic resources needed to achieve their growth objectives. For more information, visit www.iconcapg.com.
Media Contact
Calibou Group, Inc.
Investor Relations
info@calibougroup.com
